Arkolith/Insider Trading/CRXT/Form 4

Zisson Alex

Director, 10% OwnerClarus Therapeutics Holdings, Inc. (CRXT) · full profile →Form 4 · filed Sep 13, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 9, 2021Grant(A)2.7M—$03.2M
Sep 9, 2021Grant(A)2.5M—$05.7M
Sep 9, 2021Grant(A)491K—$0491K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-21-047814) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML